Valsartan + HydrochlorothiazideThird Party Manufacturing in India

Valsartan + Hydrochlorothiazide works by utilizing a dual pathway to control elevated blood pressure. Valsartan blocks the AT₁ angiotensin II receptor to prevent vasoconstriction, while hydrochlorothiazide inhibits sodium reabsorption in the distal convoluted tubules to help the body increase urine output and decrease plasma volume. Unlike monotherapy options, this synergistic combination addresses both volume-dependent and vasoconstrictive components of hypertension simultaneously. It is highly effective and well-tolerated when target pressures are difficult to attain.

Therapeutic Uses

• Combination Hypertension Therapy: Indicated for patients whose blood pressure is not adequately controlled by single-agent medications.
• Second-Line Hypertension Management: Prescribed as initial therapy in cases where rapid blood pressure control is clinically necessary.

Why Manufacturers Choose Valsartan + Hydrochlorothiazide

Valsartan + Hydrochlorothiazide third party manufacturing in India provides severe commercial advantages due to the medical trend toward fixed-dose combinations. Formulations utilizing CAS 137862-53-4 as a primary active ingredient cater directly to clinicians seeking to maximize patient adherence through fewer daily pills. Celesta Healthcare utilizes a vast supply network where partner facilities are WHO-GMP certified, guaranteeing high stability and exact dissolution profiles. Our commitment to WHO-GMP standards gives B2B buyers absolute assurance during high-volume product rollouts.